PubMed:7678256
Annnotations
GlyCosmos6-Glycan-Motif-Image
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 48-51 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
T3 | 100-103 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
T5 | 282-285 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
T7 | 328-331 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
T9 | 371-374 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
T11 | 785-788 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
T13 | 1001-1004 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
T15 | 1057-1060 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
T17 | 1373-1376 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
T19 | 1499-1502 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
T21 | 1768-1771 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
T23 | 1849-1852 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
Glycosmos6-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 48-51 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
T2 | 100-103 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
T3 | 282-285 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
T4 | 328-331 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
T5 | 371-374 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
T6 | 785-788 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
T7 | 1001-1004 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
T8 | 1057-1060 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
T9 | 1373-1376 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
T10 | 1499-1502 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
T11 | 1768-1771 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
T12 | 1849-1852 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-85 | Sentence | denotes | Mechanism of action of the monosialoganglioside GM1 as a modulator of CD4 expression. |
T2 | 86-202 | Sentence | denotes | Evidence that GM1-CD4 interaction triggers dissociation of p56lck from CD4, and CD4 internalization and degradation. |
T3 | 203-370 | Sentence | denotes | Analyzing the mechanisms underlying the capability of the monosialoganglioside GM1 to induce CD4 modulation we observed that GM1 has a dual effect on the CD4 molecule. |
T4 | 371-699 | Sentence | denotes | GM1 treatment of the lymphoma cell line MOLT-3 and CD4-transfected HeLa cells for times shorter than 30 min prevented binding of monoclonal antibodies (mAbs) recognizing epitopes located within the first NH2-terminal domains of CD4, but not of the OKT4 mAb, which binds to the region of CD4 proximal to the transmembrane domain. |
T5 | 700-1056 | Sentence | denotes | However, no binding of the OKT4 mAb was observed after a few hours of treatment with GM1 in both MOLT-3 cells and HeLa cells transfected with an intact CD4 molecule, but not in HeLa cells transfected with a CD4 molecule lacking the bulk of the cytoplasmic domain, suggesting that modulation of CD4 by GM1 depends on the integrity of the cytoplasmic domain. |
T6 | 1057-1290 | Sentence | denotes | GM1 treatment blocked binding of several mAbs which recognize epitopes located within the first two NH2-terminal domains of CD4 and did not induce CD4 down-modulation if MOLT-3 cells were preincubated with the OKT4A or the OKT4 mAbs. |
T7 | 1291-1498 | Sentence | denotes | Immunoprecipitation studies with [35S]methionine-labeled MOLT-3 cells showed that GM1-induced CD4 down-modulation was accompanied by CD4 degradation, and this was preceded by dissociation of p56lck from CD4. |
T8 | 1499-1711 | Sentence | denotes | GM1-induced CD4 down-modulation, dissociation of p56lck from CD4, and CD4 degradation were unaffected by staurosporine, which, on the contrary, blocked these events in response to phorbol 12-myristate 13-acetate. |
T9 | 1712-2037 | Sentence | denotes | These observations demonstrate that the first action of GM1 is to mask epitopes located within the first two NH2-terminal domains; then, GM1 triggers protein kinase C-independent signals which cause p56lck dissociation from CD4 and the delivery of the molecule to an intracellular compartment where it is eventually degraded. |
T1 | 0-85 | Sentence | denotes | Mechanism of action of the monosialoganglioside GM1 as a modulator of CD4 expression. |
T2 | 86-202 | Sentence | denotes | Evidence that GM1-CD4 interaction triggers dissociation of p56lck from CD4, and CD4 internalization and degradation. |
T3 | 203-370 | Sentence | denotes | Analyzing the mechanisms underlying the capability of the monosialoganglioside GM1 to induce CD4 modulation we observed that GM1 has a dual effect on the CD4 molecule. |
T4 | 371-699 | Sentence | denotes | GM1 treatment of the lymphoma cell line MOLT-3 and CD4-transfected HeLa cells for times shorter than 30 min prevented binding of monoclonal antibodies (mAbs) recognizing epitopes located within the first NH2-terminal domains of CD4, but not of the OKT4 mAb, which binds to the region of CD4 proximal to the transmembrane domain. |
T5 | 700-1056 | Sentence | denotes | However, no binding of the OKT4 mAb was observed after a few hours of treatment with GM1 in both MOLT-3 cells and HeLa cells transfected with an intact CD4 molecule, but not in HeLa cells transfected with a CD4 molecule lacking the bulk of the cytoplasmic domain, suggesting that modulation of CD4 by GM1 depends on the integrity of the cytoplasmic domain. |
T6 | 1057-1290 | Sentence | denotes | GM1 treatment blocked binding of several mAbs which recognize epitopes located within the first two NH2-terminal domains of CD4 and did not induce CD4 down-modulation if MOLT-3 cells were preincubated with the OKT4A or the OKT4 mAbs. |
T7 | 1291-1498 | Sentence | denotes | Immunoprecipitation studies with [35S]methionine-labeled MOLT-3 cells showed that GM1-induced CD4 down-modulation was accompanied by CD4 degradation, and this was preceded by dissociation of p56lck from CD4. |
T8 | 1499-1711 | Sentence | denotes | GM1-induced CD4 down-modulation, dissociation of p56lck from CD4, and CD4 degradation were unaffected by staurosporine, which, on the contrary, blocked these events in response to phorbol 12-myristate 13-acetate. |
T9 | 1712-2037 | Sentence | denotes | These observations demonstrate that the first action of GM1 is to mask epitopes located within the first two NH2-terminal domains; then, GM1 triggers protein kinase C-independent signals which cause p56lck dissociation from CD4 and the delivery of the molecule to an intracellular compartment where it is eventually degraded. |
Glycosmos6-MAT
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 662-670 | http://purl.obolibrary.org/obo/MAT_0000491 | denotes | proximal |
GlyCosmos6-Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 48-51 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T2 | 48-51 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
T3 | 100-103 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T4 | 100-103 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
T5 | 282-285 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T6 | 282-285 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
T7 | 328-331 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T8 | 328-331 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
T9 | 371-374 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T10 | 371-374 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
T11 | 785-788 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T12 | 785-788 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
T13 | 1001-1004 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T14 | 1001-1004 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
T15 | 1057-1060 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T16 | 1057-1060 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
T17 | 1373-1376 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T18 | 1373-1376 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
T19 | 1499-1502 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T20 | 1499-1502 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
T21 | 1768-1771 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T22 | 1768-1771 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
T23 | 1849-1852 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
T24 | 1849-1852 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
mondo_disease
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 392-400 | Disease | denotes | lymphoma | http://purl.obolibrary.org/obo/MONDO_0005062 |
Anatomy-MAT
Id | Subject | Object | Predicate | Lexical cue | mat_id |
---|---|---|---|---|---|
T1 | 662-670 | Body_part | denotes | proximal | http://purl.obolibrary.org/obo/MAT_0000491 |
HP-phenotype
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 392-400 | Phenotype | denotes | lymphoma | HP:0002665 |
Glycan-GlyCosmos
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 48-51 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T2 | 100-103 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T3 | 282-285 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T4 | 328-331 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T5 | 371-374 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T6 | 785-788 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T7 | 1001-1004 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T8 | 1057-1060 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T9 | 1373-1376 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T10 | 1499-1502 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T11 | 1768-1771 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T12 | 1849-1852 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
GlyCosmos-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
---|---|---|---|---|---|
T1 | 48-51 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T2 | 100-103 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T3 | 282-285 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T4 | 328-331 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T5 | 371-374 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T6 | 785-788 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T7 | 1001-1004 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T8 | 1057-1060 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T9 | 1373-1376 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T10 | 1499-1502 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T11 | 1768-1771 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T12 | 1849-1852 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
GlyCosmos15-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 392-400 | Phenotype | denotes | lymphoma | HP:0002665 |
GlyCosmos15-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T1 | 392-400 | Disease | denotes | lymphoma | http://purl.obolibrary.org/obo/MONDO_0005062 |
GlyCosmos15-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 678-691 | Body_part | denotes | transmembrane | http://purl.obolibrary.org/obo/GO_0016020 |
T2 | 944-955 | Body_part | denotes | cytoplasmic | http://purl.obolibrary.org/obo/GO_0005737 |
T3 | 1037-1048 | Body_part | denotes | cytoplasmic | http://purl.obolibrary.org/obo/GO_0005737 |
T4 | 1979-1992 | Body_part | denotes | intracellular | http://purl.obolibrary.org/obo/GO_0005622 |
GlyCosmos15-MAT
Id | Subject | Object | Predicate | Lexical cue | mat_id |
---|---|---|---|---|---|
T1 | 662-670 | Body_part | denotes | proximal | http://purl.obolibrary.org/obo/MAT_0000491 |
sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-85 | Sentence | denotes | Mechanism of action of the monosialoganglioside GM1 as a modulator of CD4 expression. |
T2 | 86-202 | Sentence | denotes | Evidence that GM1-CD4 interaction triggers dissociation of p56lck from CD4, and CD4 internalization and degradation. |
T3 | 203-370 | Sentence | denotes | Analyzing the mechanisms underlying the capability of the monosialoganglioside GM1 to induce CD4 modulation we observed that GM1 has a dual effect on the CD4 molecule. |
T4 | 371-699 | Sentence | denotes | GM1 treatment of the lymphoma cell line MOLT-3 and CD4-transfected HeLa cells for times shorter than 30 min prevented binding of monoclonal antibodies (mAbs) recognizing epitopes located within the first NH2-terminal domains of CD4, but not of the OKT4 mAb, which binds to the region of CD4 proximal to the transmembrane domain. |
T5 | 700-1056 | Sentence | denotes | However, no binding of the OKT4 mAb was observed after a few hours of treatment with GM1 in both MOLT-3 cells and HeLa cells transfected with an intact CD4 molecule, but not in HeLa cells transfected with a CD4 molecule lacking the bulk of the cytoplasmic domain, suggesting that modulation of CD4 by GM1 depends on the integrity of the cytoplasmic domain. |
T6 | 1057-1290 | Sentence | denotes | GM1 treatment blocked binding of several mAbs which recognize epitopes located within the first two NH2-terminal domains of CD4 and did not induce CD4 down-modulation if MOLT-3 cells were preincubated with the OKT4A or the OKT4 mAbs. |
T7 | 1291-1498 | Sentence | denotes | Immunoprecipitation studies with [35S]methionine-labeled MOLT-3 cells showed that GM1-induced CD4 down-modulation was accompanied by CD4 degradation, and this was preceded by dissociation of p56lck from CD4. |
T8 | 1499-1711 | Sentence | denotes | GM1-induced CD4 down-modulation, dissociation of p56lck from CD4, and CD4 degradation were unaffected by staurosporine, which, on the contrary, blocked these events in response to phorbol 12-myristate 13-acetate. |
T9 | 1712-2037 | Sentence | denotes | These observations demonstrate that the first action of GM1 is to mask epitopes located within the first two NH2-terminal domains; then, GM1 triggers protein kinase C-independent signals which cause p56lck dissociation from CD4 and the delivery of the molecule to an intracellular compartment where it is eventually degraded. |
T1 | 0-85 | Sentence | denotes | Mechanism of action of the monosialoganglioside GM1 as a modulator of CD4 expression. |
T2 | 86-202 | Sentence | denotes | Evidence that GM1-CD4 interaction triggers dissociation of p56lck from CD4, and CD4 internalization and degradation. |
T3 | 203-370 | Sentence | denotes | Analyzing the mechanisms underlying the capability of the monosialoganglioside GM1 to induce CD4 modulation we observed that GM1 has a dual effect on the CD4 molecule. |
T4 | 371-699 | Sentence | denotes | GM1 treatment of the lymphoma cell line MOLT-3 and CD4-transfected HeLa cells for times shorter than 30 min prevented binding of monoclonal antibodies (mAbs) recognizing epitopes located within the first NH2-terminal domains of CD4, but not of the OKT4 mAb, which binds to the region of CD4 proximal to the transmembrane domain. |
T5 | 700-1056 | Sentence | denotes | However, no binding of the OKT4 mAb was observed after a few hours of treatment with GM1 in both MOLT-3 cells and HeLa cells transfected with an intact CD4 molecule, but not in HeLa cells transfected with a CD4 molecule lacking the bulk of the cytoplasmic domain, suggesting that modulation of CD4 by GM1 depends on the integrity of the cytoplasmic domain. |
T6 | 1057-1290 | Sentence | denotes | GM1 treatment blocked binding of several mAbs which recognize epitopes located within the first two NH2-terminal domains of CD4 and did not induce CD4 down-modulation if MOLT-3 cells were preincubated with the OKT4A or the OKT4 mAbs. |
T7 | 1291-1498 | Sentence | denotes | Immunoprecipitation studies with [35S]methionine-labeled MOLT-3 cells showed that GM1-induced CD4 down-modulation was accompanied by CD4 degradation, and this was preceded by dissociation of p56lck from CD4. |
T8 | 1499-1711 | Sentence | denotes | GM1-induced CD4 down-modulation, dissociation of p56lck from CD4, and CD4 degradation were unaffected by staurosporine, which, on the contrary, blocked these events in response to phorbol 12-myristate 13-acetate. |
T9 | 1712-2037 | Sentence | denotes | These observations demonstrate that the first action of GM1 is to mask epitopes located within the first two NH2-terminal domains; then, GM1 triggers protein kinase C-independent signals which cause p56lck dissociation from CD4 and the delivery of the molecule to an intracellular compartment where it is eventually degraded. |
GlyCosmos15-Sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-85 | Sentence | denotes | Mechanism of action of the monosialoganglioside GM1 as a modulator of CD4 expression. |
T2 | 86-202 | Sentence | denotes | Evidence that GM1-CD4 interaction triggers dissociation of p56lck from CD4, and CD4 internalization and degradation. |
T3 | 203-370 | Sentence | denotes | Analyzing the mechanisms underlying the capability of the monosialoganglioside GM1 to induce CD4 modulation we observed that GM1 has a dual effect on the CD4 molecule. |
T4 | 371-699 | Sentence | denotes | GM1 treatment of the lymphoma cell line MOLT-3 and CD4-transfected HeLa cells for times shorter than 30 min prevented binding of monoclonal antibodies (mAbs) recognizing epitopes located within the first NH2-terminal domains of CD4, but not of the OKT4 mAb, which binds to the region of CD4 proximal to the transmembrane domain. |
T5 | 700-1056 | Sentence | denotes | However, no binding of the OKT4 mAb was observed after a few hours of treatment with GM1 in both MOLT-3 cells and HeLa cells transfected with an intact CD4 molecule, but not in HeLa cells transfected with a CD4 molecule lacking the bulk of the cytoplasmic domain, suggesting that modulation of CD4 by GM1 depends on the integrity of the cytoplasmic domain. |
T6 | 1057-1290 | Sentence | denotes | GM1 treatment blocked binding of several mAbs which recognize epitopes located within the first two NH2-terminal domains of CD4 and did not induce CD4 down-modulation if MOLT-3 cells were preincubated with the OKT4A or the OKT4 mAbs. |
T7 | 1291-1498 | Sentence | denotes | Immunoprecipitation studies with [35S]methionine-labeled MOLT-3 cells showed that GM1-induced CD4 down-modulation was accompanied by CD4 degradation, and this was preceded by dissociation of p56lck from CD4. |
T8 | 1499-1711 | Sentence | denotes | GM1-induced CD4 down-modulation, dissociation of p56lck from CD4, and CD4 degradation were unaffected by staurosporine, which, on the contrary, blocked these events in response to phorbol 12-myristate 13-acetate. |
T9 | 1712-2037 | Sentence | denotes | These observations demonstrate that the first action of GM1 is to mask epitopes located within the first two NH2-terminal domains; then, GM1 triggers protein kinase C-independent signals which cause p56lck dissociation from CD4 and the delivery of the molecule to an intracellular compartment where it is eventually degraded. |
GlyCosmos15-Glycan
Id | Subject | Object | Predicate | Lexical cue | image |
---|---|---|---|---|---|
T1 | 48-51 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T2 | 100-103 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T3 | 282-285 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T4 | 328-331 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T5 | 371-374 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T6 | 785-788 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T7 | 1001-1004 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T8 | 1057-1060 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T9 | 1373-1376 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T10 | 1499-1502 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T11 | 1768-1771 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
T12 | 1849-1852 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
GlyCosmos15-GlycoEpitope
Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
---|---|---|---|---|---|
T1 | 48-51 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T2 | 100-103 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T3 | 282-285 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T4 | 328-331 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T5 | 371-374 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T6 | 785-788 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T7 | 1001-1004 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T8 | 1057-1060 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T9 | 1373-1376 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T10 | 1499-1502 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T11 | 1768-1771 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
T12 | 1849-1852 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
Anatomy-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T1 | 678-691 | Body_part | denotes | transmembrane | http://purl.obolibrary.org/obo/GO_0016020 |
T2 | 944-955 | Body_part | denotes | cytoplasmic | http://purl.obolibrary.org/obo/GO_0005737 |
T3 | 1037-1048 | Body_part | denotes | cytoplasmic | http://purl.obolibrary.org/obo/GO_0005737 |
T4 | 1979-1992 | Body_part | denotes | intracellular | http://purl.obolibrary.org/obo/GO_0005622 |